Welcome to The Center for Gynecologic Oncology. We are very happy that you have chosen our practice as a part of your care. On the first day of your visit, please ensure to have complete your questionairre online through the patient portal located at the top of our page. Please ensure to bring to your appointment a copy of your medical records if you are new patient, a picture ID and your insurance card. If your insurance requires a referral, also arrange for this to be at our practice at least a day prior to your visit. We do have a 30 min arrival policy and we ask that you advise us if you will be unable to make it at your scheduled time.
Upon your arrival , sign in at the front desk and the staff will provide you demographic information for completion. Once you are in the examining please understand the physician will examine all of our patients in order to provide their best medical opinion. We ask come prepared on the day of your appointment.
You as the patient will be provided access to your patient portal at the time of scheduling your appointment. Our office policy is that if you have access to a computer that you log on for completion of questionairres, and here you will also be able to view your results once they are available. A summary of your visit, your next appointment and request for refills are also available on this portal.
Our office is currently working on various clinical studies. If you are interested in participating on any of the studies below please feel free to contact our research coordinator Suzette Zamora at 954-602-9723 Ext. 312 or click on the link below.
MORPHOTEK- A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer
OVA 1 Post Marketing study: Patients over the age of 18 who have been diagnosed with an ovarian cyst. To participate the patient must be scheduled for surgery. Compensation for participation may be available.Uterine
Fibroid Study: Currently enrolling patients who are between the ages of 18 and 50 and have heavy bleeding caused by uterine fibroids. The patient must travel to the office and compensation is available if you qualify for the study
All of our clinical studies are able to be found in clinicaltrials. gov if you have any further questions or want more details regarding the study inclusion/exclusion criteria.